KS106（Cat No.:I043677）is a selective small molecule inhibitor targeting specific proteins involved in cellular processes related to cancer progression and immune regulation. It works by modulating key signaling pathways that govern cell growth, survival, and response to stress. KS106 has shown promising activity in preclinical studies, particularly in inhibiting tumor cell proliferation and inducing apoptosis in various cancer types. Its high specificity and potency make it an important tool for cancer research, offering potential for targeted therapies. KS106 is also being explored for its ability to enhance immune responses against tumors.